Latest / Braver New Worlds / Science Behind the Hype: Psychedelics and Public Trust with Audrey Tharp of HotGirlPharma
Transcript
- Nathan Young: Hello, welcome back to Braver New Worlds, a podcast about the stories we need to tell for the future we want to see. My name is Nathan Young. I am your host. And so we've been hearing more and more about how psychedelics might transform mental health treatment. I count myself as someone who's had a very positive and valuable reawakening and improvement to my own mental health as a result of some psychedelic assisted methodologies. And I've also been surprised to recently learn just how soon more and more psychedelic assisted therapies are likely to pass FDA approval and become available as mainstream medicine. so then the question becomes, how do we mitigate the hype and overpromise that comes with some of these treatments, even though there's like very genuinely promising therapies, but there's also reality that there's just no silver bullet or like one hundred percent effective miracle cure, especially when it comes to things of mental health. Like you're gonna have to do your work outside of the treatment in order to get the value out of it. And that's not gonna come very readily for everyone, right? And this question matters because that hype can undermine trust just as surely as the stigma can shut down a useful conversation. If people go into one of these psychedelic assisted sessions expected to come out fully cured and they don't, they might just walk away from it completely, think it's a a joke or a scam, and not really engage with the work that they need to do for their benefit of their own mental health, even though they've got this tool that could potentially be so helpful if they just maybe put a little bit more realistic effort into it. So my guest today is Audrey Tharp. she is a clinical research professional and a science communicator who runs the account Hot Girl Pharma. She works at the intersection of pharmaceutical research, psychedelics and public education. And we talk about the ways that media and individuals can understand the reality of these very promising studies And getting an expectation in our heads that's different from the reality. we also talk about why the therapy around a treatment matters and how social media can make accurate science harder and harder to share. I've spent a lot of my time and my work thinking about how scientists communicate beyond their own field. So I always like to explore what it takes to make science understandable without flattening the complexity. And now we're in this spot where we're merging science and mental health and these like new, again, potentially really valuable treatments. it's like ticking all my boxes for me. So I'm excited to have this conversation. if you are into scientific discovery, mental health, psychedelics and media literacy comes up here again. We're talking about media literacy all the time on the show. so if any of those interest you, then this is the conversation for you. Let's get into it. Audrey Tharp, welcome to the podcast. Audrey: I am so happy to be here, Nathan. Thank you for having me. Nathan Young: All right. So as I like to start all these podcast conversations, I just have you introduce yourself real quick to the folks at home. Audrey: I'm Audrey Tharp. I am a medical science professional, is how I like to position myself. And then I also do science communication. I have my undergraduate degree from Macquarie University in medical sciences, about five years of clinical research in biotech and pharmaceutical development, and most recently got my master's in psychoactive pharmaceutical investigations from the University of Wisconsin-Madison. I have my own little science communication media and live platforms. It's under the name Hot Girl Pharma where I do live lectures around San Diego and looking to develop farther. And then I do educational media through my website, hotgirlpharma.com, and also on TikTok and Instagram under the same name. Nathan Young: All right, cool. And so yeah, and I gotta ask, why Hot Girl Pharma? where how did you pick that name? Audrey: I went into it knowing that I wanted to be on media and something that's been really I'm like trying to the right word, very dominant in media recently is that hot girl pharma or hot girl branding. There's hot girl Nathan Young: Yeah, yeah, okay. Audrey: walks, there's even a company called Hot Girl Pickles where they make pickles and stuff like Nathan Young: Yeah. Audrey: that. And so I was like, I knew I wanted to sort of bridge this world of science and media and science Nathan Young: Mm-hmm. Audrey: communication. So I was like, okay, I'm gonna take pharma from pharmaceutical, even though I am in psychedelics and psychoactive, using the name Hot Girl Psych might have positioned myself in a different like psychology area. So I was like, I'm to take hotgirl as the media side and then pharma as my science side and put them together and that's how I got hotgirl pharma. Yeah. Nathan Young: Okay, cool. Well I love it. I've kind of not only resigned but almost like embraced the fact that we kinda have to have personal brands these days. And and and Audrey: yeah. Yeah. Nathan Young: I don't like it, but if I have to do it, fine. I'm gonna be into it. So I I hear you on that one. So Audrey: Yeah. No, I I very much am saying just my name. I felt like it wasn't an attention grab and I like, you know what, this might grab someone's attention that might ignore my name. So we'll see if this works. Nathan Young: Yeah, yeah, yeah. Yeah. Yeah, you gotta have three names if you wanna get that's why I do Nathan Cody Young. That's like you gotta get do it that way. Audrey: Yes. Yes, yes, yes. Yeah. You gotta differentiate yourself from everyone else. Nathan Young: Yeah, yeah. Cool. And okay, so then the other thing you said your masters was in psycho something clinical research. What's that all about? Tell us about that is again. Audrey: Yes. so University of Wisconsin Madison is one of the first US based institutions to have this master's program in something that's so specific to psychoactive substances. They were hesitant to label it psychedelic because if we're talking very grammatically correct, psychedelic is a very specific class of drugs and there's other psychoactive or developmental substances that very much don't fall under that psychedelic title. So we have things like MDMA, that's not a psychedelic, but people might assume it is. Also things like ketamine, they fall Under that psychoactive title without it actually being a psychedelic. So that's where that name comes from. And then the pharmaceutical investigation component of it is you learn everything about how pharmaceuticals are developed, research, how they go into practice, how they're approved by the FDA. And then you learn all everything about how psychedelics tie into that, the neuroscience behind everything, the actual science behind these substances, and then what research needs to be done, what research has been done to be able to implement these into clinical care practices. So it sounds like it's a lot. And I felt like I learned so much there. The people there are amazing Nathan Young: Yeah, yeah. Audrey: and it's a very fully encompassing degree, but it's digestible information and it's one of the only programs of its kind. So it really is unique and futuristic in a way, and I hope many other institutions kind of follow in their footsteps and implement these more academic institutions around psychoactive substances. Nathan Young: Yeah. Well and it sounds important too because okay, because the way we originally met was you came to the event one of the events for the event series, I have a big Audrey: Yes. Nathan Young: idea night and you came to the event with Lynn Marie Morsky who talked about she Audrey: Morsky, yes. Nathan Young: is the president of the Psychedelic Medicine Association and trying Audrey: Yes. Nathan Young: to get psychedelics more legalized and available. And what surprised me so much from her talk was that how close so many of these are to becoming FDA approved, illegal and available. And I I had no idea. I knew this was like something that might happen in the future. But she's like next year. Or end of this year, next year, it's coming. Audrey: Yeah, and it always shocks people when I was like, No, there is actually a legal form of medical marijuana in the form of epidiolex. we already have psychoactive substances that have their FDA approval. Also ketamine, it has been approved for the depression resistant treatment and stuff like that. So I think people don't realize just how far along we are. And there have been blockers. It's it hasn't been going up for Nathan Young: Yeah. Audrey: as much as we would like, but there is a lot of progress being made in it and it's sooner than we think if we're being completely honest. Nathan Young: Mm-hmm. Yeah. Well, it sounds like the sort of sociological emotional thresholds that I grew up with the war on drugs era, it seems like that's kinda not there the same way either because this would be if a lot of these substances made legal in the eighties, that'd be Satanism, essentially. that's how it would have gotten framed. Audrey: Yes. yeah. Yeah. Yeah. Nathan Young: There just seems to be a lot more of acceptance what I find so interesting. Audrey: yeah. And it's it's funny 'cause actually in one of my courses in my masters, we sort of talked about how the script has flipped and it's almost like we're trying to prevent people from making it so hyped. We're like, Wait, it's not this people keep labeling it as like a miracle drug. It will cure all there's different substances. They're like, my god, it cures suppression, it cures PTSD, it cures addiction, and it's like wait just a little bit if you overhype Nathan Young: Hold up. Audrey: it and if if you go too far with this and then all the science is saying, Well, we're actually here, it's gonna cause mistrust again. So we have to mediate our response to it. And it is really exciting and I love how people are really gunning for getting funding behind this and getting it approved. But then we also have to be sure we're not falling into this overhyping it and then eventually causing mistrust. Nathan Young: Yeah, yeah. Totally. Well then all of also all of this is to say good, I'm glad there are programs out there for people like you to get trained in this and be able to talk about it. So Audrey: Yeah, no, it's amazing. Yeah. Nathan Young: good. So the other thing is I'm curious to know a little bit about how you got into this too, because I know a lot of people, again, kinda coming from my perspective outside science and people have been gunning for this for a long time, but they're more people coming from a point of view of just having maybe experienced the benefits on some levels in their own just personal life in these extra legal ways that it's been going on for many, many years. And Audrey: Yeah. Nathan Young: I hear you coming at it from a very scientific point of view as far as this. But I also know that you shared a little bit with me in the information you gave me to read before the episode about what got you inspired by this too. So could just kinda tell us a little bit more about how you got into all this? Audrey: Yeah, yeah, of course. I did my undergraduate degree in Australia, which kind of shocks a lot of people. They're Well, what made you go out there? I'm gonna give a little shout out to my sister. She did her undergraduate degree in Scotland, and I am two years younger than her, and I was like, wait a minute, that actually sounds really cool. And at that time, I very much sort of like stepped away from playing. I still played sports, but the only reason I wanted to go to a school in America or in the United States was the possibility of playing a sport in college, and I kind of dropped that. I got injured, I was like, I should have bank my whole career on athletics. Which had always been on the science side from a very young age. And I was like, I'm gonna look at a couple programs in Australia. I always wanted to go there. I had a young fascination with it from a young age. And I found this institution, Macquarie University, and they had a really cool undergraduate degree. I'm a little unsure if they still have it now, but it's just the fully encompassing undergraduate degree in medical sciences. That Nathan Young: Mm. Audrey: was the entire title. it covered everything from clinical side of it to the research side of it, and that was my first time being introduced to the research aspect of science. I'd always thought I was going to be like a doctor or a practitioner or something like that, but I was like, wait, this looks really cool. And I took two courses, Drugs Across Cultures, and then also Delusions of Disorder of the Mind and Brain. And those introduced me to different substances and then also living in Australia very different drug culture than we have in the United States. And I will say I've had my own personal recreational experiences with these substances. And that is initially what made me go, wait, these might have more merit to them than I actually think. And that's when I at a young age, I think I was nineteen at the time, I went, This is something I want to know more about. And so I was introduced to the book PiHKAL, which is Phenothalamines I've Known and Loved by Dr. Alexander Shulgin. And he Nathan Young: Okay. Audrey: is the man that synthesized MDMA for the first time. And Nathan Young: Mm. Audrey: so this really opened up the world of like it just kept going. Every single page that I turned when it came to discovering this field, I like, This is so much more fascinating than I thought it would be. Around all of this, my father was struggling with alcohol use disorder. And he had been in and out of rehab. He tried many different institutions. He tried different therapy practices and almost nothing was working for him and he was really struggling. And so I already being exposed to this world of psychedelics, I was like, wait, I've heard research around this happening. And I had found this one research program out at John Hopkins where they were doing psilocybin assisted therapy for alcohol related depression. And I was trying to get him into the trial. I was working with his doctors. I was working with the people that were out there, their recruitment team, and during that whole process he ended up passing away due to alcohol related issues. And that really made me go this is what I need to do. And I was employed at the time when he did pass, I was working in biotech research. And I wanna say within two months of his passing, I was applied to University of Wisconsin Madison psychedelic program or the master's research program. And I had found it through a Google search. Everyone's always like, How did you find this? I typed into Google one day. I Nathan Young: Good old Google. Audrey: typed in psychedelic master's program because I had been considering PhDs. I hadn't found anything. I will say my undergraduate GPA going from Australia to United States, it doesn't transfer the way that like a normal they do a seven point scale. When you transfer it here, I almost flunked out of my undergrad when you transfer it to the four point scale. And so I was like, I can't go straight into a PhD, they're not gonna take me. And so I did the master's program and ultimately it was the best thing that I ever did. the facilities that they have there for research, they are doing their own psychedelic research there. And the people that are there, not only the professors, but also the people in the program are honestly phenomenal. And while I was there, I focused almost all of my independent research efforts on psilocybin assistive therapy for alcohol use disorder. And that's how I ended up where I am now. And it's a long story. And I tie it all back, I say it's a butterfly effect to when I got injured in high school. Cause I don't think I would have gone to school in Australia. I don't think I would have ever been introduced to these substances or these classes. And I don't think I would have ever gone to the masters if it wasn't for that. Nathan Young: Yeah, yeah. Wow. Well yeah, no, thank you for sharing that story. And I can see how Audrey: Yeah. Nathan Young: you're already sort starting to go down that road and then you get this like, no, this is I must do this set of sort of path there. So Audrey: Yeah. Nathan Young: yeah, yeah. It's one of the things I'm curious in too, and I think that this is so interesting is kind of from my perspective also had my own sort of recreational experiences with it, and there's always a certain type of person that has been into psychedelics. And I think that's very much a stereotype of the kind of person that Audrey: Yes. Nathan Young: I encountered. But also more and more just through talking to Lynn Marie and having that event that we had and there's a much just the points of view that people are bringing the psychedelics nowadays is so much more diverse and so much more interesting. And it is interesting to me just to see this very like straightforward science focus on the value of these medications and stuff too. And so I guess I'm kinda curious, with in your program, to what degree were people coming from it just 'cause, maybe this is anecdotal, like just they're curious about the science versus they really were excited about, these potential medications and these substances for what they did. Or vice versa. Audrey: Yeah, no, that's a really great question, and that's one of the reasons why I love this program so much, because it was everyone. We had people that conduct ayahuasca retreats and psilocybin retreats wanting to learn more about it. We had people that had just dabbled in it and were very interested. They also have something just called a capstone certificate. So it's a smaller amount of courses. It only takes about ten to sixteen months to complete. So you just had people that were intrigued and were like, I kinda wanna learn a little bit more without the full commitment. you had palliative care doctors that were trying to implement psychedelic practices into their care. church leaders, you had people like me that were really interested in being in the clinical research side of it. So it covered and I'm probably missing so many people right now, but it covered everyone it and everywhere and it really made it such a unique process because you were able to hear so many sides of it. Nathan Young: Yeah, yeah. I love that too, because it is and one of the things we were talking about right before we hit record was just this there's just so much this new scientific focus and knowledge. It's almost kinda like the hot science on some level, I guess. Well I guess there's a lot of hot sciences Audrey: Yeah. Nathan Young: and stuff nowadays, like I and whatever. But it's such an interesting topic because there is all this new science emerging and a lot of very well studied science. But then there's also people that have been studying this, maybe not quite so clinically, but have a lot of wisdom and experience to share around these medications Audrey: Yeah. Nathan Young: and these substances for like decades and longer, eons, centuries too, right? Audrey: Yes. Yeah. we and I'm speaking for a whole and when I say we, I'm talking about the research industry, the academia industry, are very, very aware of the cultural and indigenous tribes and communities that have contributed to this research when it hasn't been federally legal. There have been a lot of like grants and I don't like saying legal loopholes, but just ways that different people have been able to practice and continue almost studying these substances without the rigor that the science and academia industry has. But their knowledge is so valuable to us. And it's something that we try so hard to not to discredit and always incorporate into what we do. And I always touch on it ever almost every single talk that I give, almost every single person that I talk to, I'm like, this is something that is happening. We aren't ignoring it, we're doing everything that we can to where if it does become a clinical practice, if it does become something that has FDA approval and you have to get a prescription for it, that these communities still have access to it and they aren't losing something that they almost like gave to us in a very beautiful, full picture way. Like we really try to acknowledge their knowledge. Nathan Young: Yeah, yeah, totally. Cool. Well then also, so you dropped kind of what the idea that I want to segue into here next in there a little bit too, is that yes, you were out there talking about this, but it also sounds like you're not necessarily talking about this in connection with just explaining the pure science per se, but more there's just a lot of voices talking about this and some of them are speaking to it from a very educated point of view, maybe whether that's like a academic education or another kind of education, and some are just spewing all kinds of crazy stuff and everything in between. And then there's also the receiving side where people are you some of us can I don't necessarily count myself as that good at deciphering science, but I have a pretty good idea of what it means when I hear studies show. It means a study, a study, said this. Audrey: Yes. Nathan Young: one PhD out there. One PhD candidate out there did a study that Audrey: Yes. Yes. Yes. Nathan Young: said this. And maybe it's legit, maybe not. I know that. But other people hear like studies show and they're like all aboard and this becomes a new thing. So It sounds like yeah, a lot part of where you are pivoting to is to try and maybe take up the mantle of helping people understand that communication. Am I getting this right? Audrey: Yes, yeah. I it's weird because Public speaking has always been something that's terrified me, but my mom has told me from a young age I've always done. Which I'm like, that's in that's very interesting. I don't understand the reason Nathan Young: Mm. Yeah. Audrey: behind it. But I've always been told that I articulate science very well to people who wouldn't necessarily be able to understand it. And I think that comes from when I started having a passion for science, I was at a young age, but it wasn't something that came naturally to me. It's that's something that people always assume about me. They're like, you've done this from such a young age. all my family and friends are like, They come to me and they jokingly are like, Hey, I need help with this. I don't know why you think I'm like a primary care provider, but Nathan Young: Mm-hmm. Audrey: I do my best I do my best to understand Nathan Young: How young were you when this happened? Audrey: they do it to this day. I'll get sent a photo of blood work and I'm like, I don't like 'cause I worked in blood diagnostics for three years. They're like, You Nathan Young: Okay. Audrey: you know what normal values are and I'm like, I from what they said on their devices, I'm like, but anyways, It's something that I had to teach myself. It's something that I had to learn. I had to break down the really gritty scientific articles and understand the jargon behind it. So the fact that I was able to do it for myself and then also I have a side of coaching. I've always coached since starting in high school. I've coached lacrosse. I've coached basketball. I like learned how to play rugby when I was 19 years old. it's something that I know how people learn. And I've also sort of started to understand the art of how to teach people and communicate things in a way that is digestible to multiple levels of knowledge. I've communicated to children, at conferences, poster presentations. So there's a range of knowledge and it's something that I really pride myself on on being able to articulate this science to a wide variety of audiences. And that's why I was like, I want to do this. And I have a couple other friends from my program that do this sort of like social media engagement too. they're out in New York, there's one in San Clemente and they do a really good job of communicating it and it's something that I think every single person who has the talent to be able to do it should do it. We Nathan Young: Yeah, yeah. Audrey: are in an a day and age where science is almost too at people's fingertips and it makes people that aren't necessarily I try to tread lightly here. who maybe not have the right credentials or the right knowledge around topics feel empowered to talk about things. Nathan Young: Mm-hmm, mm-hmm. Audrey: And it's something that I always try to caution people on. I'm like, don't ever feel like you're the smartest person in the room. Don't ever think that you can't be corrected. Nathan Young: Yeah. Audrey: You have to be able to be like, yeah, I goofed up there. Like there was a time in Nathan Young: Mm-hmm. Audrey: a video I said a word wrong and someone corrected me. And I was like, you're so right, totally my bad. And you have to be willing to do that when you put yourself out there like that. So I like to think and this might be me bragging a little bit, I like to think that I'm I'm good at this, I wanted to do it, and I can take construction and criticism well and am willing to be able to do what is needed to be done for the science community to articulate these papers and studies and research appropriately. Nathan Young: Yeah, yeah. Well so I'm curious then what are some of your observations on maybe I'm not sure where to start. If we want to start with okay, how is maybe the way science is trying to communicate it not really getting across or what are the individual communicators they're doing it better or worse, or maybe people on the receiving end of the communication, what are they perceiving correctly or incorrectly? I mean, I don't know, is there any observations you can s sort of share about that spectrum somewhere? Audrey: yeah, that something that I'm really passionate about and I actually think Rick Doblin just touched on this in another podcast. he's someone that's pretty influential in the psychedelic research world. is that there has been so much emphasis put on the psychoactive substance itself. And there's been a lack of attention and knowledge around the therapy components when it comes to when we're talking about it as a treatment. When yeah, so it's like when we talk about psychedelics helping someone with PTSD, we're not saying the substance was the medicine. It was the substance in conjunction with the very strict protocol and therapy behind it that Nathan Young: Yeah. Audrey: allowed the person to receive a treatment that they otherwise wouldn't have had access to. So Nathan Young: Mm-hmm. Yeah. that's an interesting point too, because yeah, it doesn't the substance by itself isn't necessarily doing the work. it's opening up neural pathways that maybe didn't exist before if I'm getting this right, if I'm getting my science right. And those Audrey: Yes, you are. Nathan Young: neural pathways can be reconnected with newer, I don't brain connections that are more positive or pro social or just serve you better in life than whatever the previous neuropathways right or were, right? Is that okay. Audrey: Yes. Yeah, no, you you have that down. That's good. it's something that we call neuroplasticity and it's a word that's become yeah, it's become a buzzword in science. Nathan Young: Mm. That's the word. Mm-hmm. Audrey: but it's basically just this idea that psychedelics and there are other things that it can enhance your neuroplasticity. This isn't just something that's specific to psychedelics or psychoactive substances. They enhance communication across parts of your brain that wouldn't normally communicate, and it allows you to develop a new neural framework around the way that you think about things. So I'm trying to think of an example, someone suffering from PTSD. Nathan Young: Mm-hmm. Audrey: They might not be able to talk through their traumatic event or events without it triggering a really dramatic response within their body. So something that they've seen with psychedelics, particularly MDMA, is that it inhibits your what people call like your fight or flight response. allows your body to process through it in a way that wouldn't normally necessarily be accessible and therefore it's more therapeutic and they're able to work through it. Nathan Young: Yeah, yeah. Well that's a good example too, because yeah, there is a possibility maybe I don't know how possible this is, but if you have that PTSD and you take a psychedelic and you could have an experience that would exasperate it even more, right? You may have noticed that one of the recurring themes of this podcast is that the world as it is isn't the only world that's possible. And the people I talk with on here are often exploring different ways of leading, working, building community and creating change in the world here too. And you also may have noticed that we have a few problems in our world. Things aren't the way that a lot of us would like them. And many of the guests I've had on here have had on specifically for the ideas they have to share about what could make our world a better place. and this all gets back to the kind of work that I do too. This connection of leadership and social change. Very much part of the work I do. I work with leaders to help them own and share their own bold vision for a better world. Sometimes this means helping someone find the message in the heart of a talk they're giving or an overall message they're sharing about who they are and the kind of work they're doing. Sometimes it means helping an organization tell a clearer and more compelling story about the work they're doing and the change they're trying to make. And sometimes this even means helping my clients understand what it means to be courageous and applying that courage to the message they wanna share. Right now I do this primarily through coaching and consulting with leaders specifically, but also with some small organizations. I'm also developing a set of tools and training models an idea I call narrative leadership, which is a framework for understanding how the stories we tell shape what we believe is possible and our ability to make these stories real. And I'll be sharing much more about this work here soon. So if any of this sounds interesting, it sounds like something that you could use help with for your either for yourself or for your organization, I'd love to hear from you. I'd love to see if we could work together. you can start by visiting my website which is storyculture consulting dot com or finding me on social media and all the channels. It's Nathan Cody Young on all of them. There are ways you can message me either through social media, through the website. So get in touch with me that way. And of course keep listening here. I plan to roll out some pieces of this here very soon. So as more and more of that comes together, you're all gonna be the first to hear about it. So thanks so much for listening to my little commercial here, And now let's get back to the episode. Audrey: yeah, I also feel like this is something that people don't talk about on social media. The exclusion and exclusion criteria, so that's the criteria that researchers set to be able to include someone into a clinical trial isn't extensive and long and very comprehensive and it covers things like If someone's had a family member that's had a past episode of psychosis or schizophrenia, psychedelics have the component to be able to trigger that in someone. So Nathan Young: Yeah, yeah. Audrey: we are very cautious and we screen almost everyone out that has that sort of component. most studies ask for someone that what we call isn't psychedelic or psychoactive naive. So that usually requires having a prior positive experience with psychoactive substances. So that's kind of how there are safety measures in place. Now it's not a foolproof plan, almost nothing is, but we do have safety measures in place to ensure that we are keeping the criteria specific and we aren't harming people in the process. Nathan Young: Yeah. Yeah, yeah, yeah, definitely. No, it's I mean that's interesting 'cause it is yeah, and I mean definitely know of lots of people that have had positive experiences with this, but also, people that have like, it could be anything just doing something really stupid because that's not really where your Audrey: Yeah. Nathan Young: mind is. Your mind's in another place and it's looking at the world differently. And then you think like, I can swim out to that island out there. And it doesn't Audrey: Yes, yeah. Nathan Young: always it's not a good thing to do. So yeah I guess I'm really curious about these other sort of scientific things. Cause I feel like you brought up some examples in the information you sent me beforehand too of just things the public gets wrong in the way that they understand the science too, and might be like might Audrey: Yeah. Nathan Young: kinda take that in different directions without really understanding what they think they're understanding. Audrey: Yeah. I'm trying to think of a couple of examples. One that comes to mind right now is people read one paper and they're like, look at that. It cured it Nathan Young: Mm-hmm. Yeah. Audrey: it cured seventy percent of the participants. We gotta we gotta put it out there. And a Nathan Young: Yeah, yeah, yeah. Mm-hmm. Audrey: big thing in science is it your results have to be reproducible. So if we were to go Nathan Young: Mm-hmm. Audrey: to another scientist and we would be like, hey, here's the exact protocol they followed, get a different patient population and reproduce the same results and they can't do it, there's something more at play here. We aren't able to have concrete evidence. So that's why it takes so many years and so many studies and Nathan Young: Mm-hmm. Audrey: you have to make sure you're getting people from all populations. and you're considering multiple demographics in it. Otherwise you can't be Nathan Young: Yeah. Audrey: able to help a wide population of people. people. I'm trying to think of some other ones if you can think of any and kind of snowball them at me. Nathan Young: Well I I think that one you just mentioned there that's such a good one too because one paper is one paper, right? And it's like one PhD student or one lab did this study. Audrey: Yes. Nathan Young: And it's most likely a very legit study, but also they might not necessarily have been trying to study do these psychedelics like make your psychology better. They could have been trying to study something else and noticed Audrey: Yeah. Nathan Young: that, or they've kind of just would try to be studying some niche aspect of the safety of the medicines or if they could be delivered in this certain way with efficacy and weren't really designing the study to really figure out how they worked in this broader scale that people might look at it and see, right? Audrey: Yeah. Nathan Young: So these are things that happen. Audrey: No, that is very right. What you're describing is like what researchers call their primary outcome versus their secondary outcome. So their Nathan Young: Mm-hmm. Audrey: research question in a paper is going to be really specific. Like, does this medication cure this one very Nathan Young: Mm-hmm. Audrey: specific component? And then it's like, but here are all the other things that might it also treat. That's kind of how we found insulin. They developed it, can't remember right now for what, but then they realized they're like, wait, this actually really helps diabetes. Let's Nathan Young: Mm-hmm. Audrey: sort of roll it out for that. So something that was a secondary outcome ended up becoming a primary outcome and that's why it's so comprehensive and why you're seeing research papers, it started really broad and they realized all the things and now they're trying to get really specific so they can be like these are the direct outcomes of each treatment indication and each protocol and each substance. Nathan Young: Yeah, totally. Yeah. Well point you said too about how it has to duplicated and also Audrey: yeah. Yeah. Nathan Young: maybe there's some factor in the people that were chosen for the study in Wisconsin versus the people that were chosen for the study in California versus the people that were chosen for the study in like Kazakhstan, there could be Audrey: yeah. Nathan Young: completely different factors in the lives of the people that are chosen and available to be involved in these studies and the people that are doing the studies, just different variables in a study, that's not the none of these are happening in vacuum. And so I guess I always try and think of the world. I was always very science adjacent and I remembered this idea of data points. I'm always trying to think of the world at data points. And so a study's like a very solid it's a good cluster of data points, but you still gotta get data from Audrey: Yes. Nathan Young: re reproducible data from other sources and everything to really have any comprehensive knowledge on something. Audrey: Yeah, I can speak to I work currently right now in clinical research for pharmaceutical development and we have a study where this is just one study for a substance that has already had multiple other studies and they're doing it at sixty sites and it still isn't enough. they're gonna have to do more and more and more and so you really have to be wide with that and Being so focused in psilocybin assistive therapy for alcoholic use disorder, I can flat out say almost seventy percent of the population that they research is older white men. We're talking people Nathan Young: Mm-hmm. Audrey: in 30 to the 60 age category, almost predominantly white men from the United States. So and there are studies that are happening in Portugal, there's studies that are happening in the UK, but it's so densely focused in this one demographic that we have to do more demographics. We have to include more diverse Nathan Young: Mm-hmm. Audrey: populations and also the severity of the indication. Someone that's suffering from something mild versus severe, you have to do all these different studies to figure out what categories Is the best for? Is it good for every single person on this spectrum, or do we have to focus it on certain people and stuff like that? Nathan Young: Yeah, totally, totally. Well, there's no magic pill, right? And I'm on all kinds of different medications these days. And I even one of the things I always trip out on is you're probably familiar with Reddit. Some people listening to this podcast are from probably familiar with Reddit. And if you go look up different medications on Reddit And find the subreddit for it. The posts will be like, This medication saved my life. This medication almost killed me. This medication saved my life. This medication almost killed me. That's how you Audrey: Yes. Nathan Young: so people can have very different and obviously both parties in that are exaggerating because they're both there to post Audrey: yeah. Nathan Young: about it on Reddit. But there is such a diversity of experiences that people can have on any medication, even after it goes through all the clinical trials and everything else too. So yeah. Audrey: Yeah, I'm almost not scared to admit this, but I am always on Reddit because that's where you'll get probably the most comprehensive Nathan Young: Mm-hmm. Audrey: and super in-depth conversations around substances. Like Nathan Young: Yeah. Audrey: ones that I just started really getting into because I've had so many friends they're like, Hey, you're in pharmaceutical research. What about this peptide? And I'm like, Can you Nathan Young: Mm-hmm. Audrey: Wait, I'm like, don't don't put anything in you. I'm like, hold on a second. And so it's like, I will go there and I will see what people are saying because it is so broad, it is so wide, and they get so specific in a way that Nathan Young: Mm-hmm. Audrey: you can't do on other platforms. Something Nathan Young: Yeah. Audrey: I think I put in the form that I was talking to about is when I speak on TikTok and Instagram I when I first started making videos, almost every single video I made got deleted because I'm saying the full substances. I'm saying the cannabis, THD, I'm saying psychedelics, I'm saying the Nathan Young: Yeah, yeah, yeah, yeah, yeah. Mm-hmm. Mm-hmm. Mm-hmm. Audrey: full names, and they like to censor that 'cause they think Nathan Young: Yeah. Audrey: that you're promoting something that's inherently bad Nathan Young: Mm-hmm. Audrey: or it could be harmful to someone that doesn't have the proper knowledge around it. Nathan Young: Mm. Mm-hmm. Audrey: I don't think I've ever interfaced with social media so much in my entire life, but I was calling TikTok and things like that, being like I am education. I'm like Nathan Young: Mm. you actually called him? Audrey: emailing them, I'm finding numbers and I'm getting connected to AI robots. I finally get a message back that's all my videos got re uploaded. And I was like, Okay, I'm not being censored the way that I was before, but Nathan Young: cool. Well good for you. Mm-hmm. Audrey: the fact that someone like me or in my position might have to call certain substances and nickname to be able to communicate education is bizarre to me. But Nathan Young: Mm-hmm. Mm-hmm. Yeah. Audrey: I also understand it, we're in this world where people are promoting things that could be harmful to someone who doesn't have the right knowledge. But then it really also censors the people that are trying to do the right thing. And so it's Nathan Young: Yeah. Audrey: probably one of the biggest things that I've been struggling with when it comes to communicating in a media format is communicating properly without being docked or censored in a way. Nathan Young: That's so interesting because yeah, I have had people on the podcast where their clips we'd put out or we'd publish would get what's the word called? It wouldn't get censored or kicked off, but it would just get throttled. It wouldn't get Yeah. Yeah, yeah. Audrey: Restricted. Yeah. Yeah. All of a sudden it can only go to people over a certain age. They don't put it anywhere to be promoted, Nathan Young: Yeah. Audrey: stuff like that. Nathan Young: Yeah, yeah. And it'd just be quietly not pushed or anything. And Audrey: Yeah. Nathan Young: yeah, that is such a frustrating dynamic, especially because these are important topics to talk about. And if somebody's coming at it from a place of knowledge, then that should be out there. but at the same time I'm also like, Well, there's so many other Yahoos that'll just jump on there and say whatever they want on Audrey: Yep. I know, it's almost everything when it comes to media, it's like a double edged sword. You have to be willing Nathan Young: Mm-hmm. Audrey: to have that censorship and it needs to be there. there's a reason that it's there, but at the same time then everyone else is stuck fighting for the proper communication. So Nathan Young: Yeah, yeah. Well so I'm curious what you've discovered as far as how that communication's been going too, because that is I don't know exactly how old you are, but I'm guessing you were more of the generation where I had to figure this out and we didn't have the internet at all when I was growing up and it might be a little bit more native to you. And Audrey: Mm-hmm. Nathan Young: I guess I'm kinda curious how that has been going for you to just be trying to communicate these ideas online, especially on it sounds you're on TikTok and everything, doing those kind of platforms. I mean, are people receptive? Do you feel you're able communicate the way you want? how much are you moderating how you communicate for each channel? Yeah. Audrey: I'm talking pretty casually and freely. I kinda did some videos where I was a little more structured and I had lightings and photos and things like that. I didn't get the best feedback. Those videos were longer. Nathan Young: Yeah. Audrey: I break things down to two minute videos and I talk pretty casually and pretty informally to the camera, and those do really good. But when I say informally, I'm not breaking things down to a level to where it's like nicknames and I'm still talking I'm educating people on the scientific jargon in a way that is comprehensible. So there's a little bit of dumbing it down, I would say, to more just like talking to a normal person rather than these super scientific terms. Nathan Young: Mm-hmm. Audrey: but People are really receptive to it. I have a lot of people that are like, yeah, I've learned about this through here and I'm happy to learn more. this is really cool. and they leave questions and comments and they're interacting with each other in the comments too. Nathan Young: Cool. Audrey: So I've been most recently just did a video on terpenes that are in cannabis and there's a conversation, one of the I can't remember which platform it is, but there's a bud tender that is like, Yeah, I'm always telling people to journal things instead of just like go based off of what is said on Instagram. And then they're exchanging their own experiences with various terpenes or the papers that they found on it. So it not only am I helping educate people, I'm also almost bringing people together that they're able to get knowledge from other sources. So I've had a pretty good positive feedback so far and it's been really fun and People are really eager to learn about it. I've been shocked and a lot of people are like, How did you get into this? And I'm like I'm totally willing to tell people about it but Nathan Young: Just I'm on TikTok. Audrey: I bumbled my way into it. I almost feel like Nathan Young: Yeah. Audrey: I saw something I was interested in, I was like, I'm gonna I'm gonna go with it. Nathan Young: Mm mm. Yeah, yeah. Yeah, you could just record yourself and just post it, right? Audrey: Yeah, it's very easy. and I'm almost like, just give it a go. See if it works out for you. If you don't like Nathan Young: Mm-hmm. Audrey: it, you don't gotta do it. But I feel like everyone should give it a try. Nathan Young: Yeah, totally, totally. I really am fascinated and impressed by that because I think I mentioned this to you when we talked on the phone or something about how I do communication training and I've worked with scientists and one of the things that they so many of them struggle with is they just go into science mode and they start talking using the jargon that's very common in Audrey: Yeah. Nathan Young: science. And it's not like how anybody talks outside of it. And so it becomes hard to follow and you're just like, they're throwing out so many acronyms and then Audrey: Yeah. Nathan Young: ways they're like this instance of that protocol of this ICG and you're like, what's happening? Audrey: Yes. Yeah. no, I almost feel and I'm speaking from personal experience, when you get to throw out little fancy words like that, it almost gives you a little boost. You're like, I know more but then at the same time you're doing nothing for the person you're talking to. And Nathan Young: Mm. Yeah. Mm-hmm. Mm-hmm. Yeah, totally. Audrey: it's like if you are just communicating like you're presenting your poster at a conference. You're presenting to people that you know are educated. Those fancy words do a lot for you. They add a little bit of credibility to you. They make Nathan Young: Yeah. Audrey: you seem like more knowledgeable in an area. But when you're talking to the general public, it really separates you from them. They Nathan Young: Yeah. Audrey: go like, I'm gonna have to go Google 50 words after this because I have no idea what they were talking about. And it Nathan Young: Yeah, yeah. Audrey: makes them so disengaged. the second that I And I I'm guilty of this. The second that I start not being able to understand what someone is saying, I'm like, Ugh, I'm I'm swiping, I'm scrolling away because Nathan Young: Mm-hmm, mm-hmm. Yeah. Audrey: you've made it inaccessible to someone who's not knowledgeable in this area. And Nathan Young: Yeah. Audrey: that's my goal is I want someone to be able to click on a video or scroll through a video series and be like, Okay, I get it. I get the flow of this, I can follow it, I know what she's talking about, and this is really informative and I don't feel isolated. Nathan Young: Mm. Audrey: isolating someone or making topics inaccessible to the general public is just not something that needs to happen in today's world. Nathan Young: Yeah, yeah, for sure, for sure. yeah, so I'm very happy that people like you are out doing this because as I said, I've always been adjacent to science. I've been a fan of science and I was even as a young age, I always just loved science. And I got hooked on those cosmos shows with the original cosmos with Carl Sagan and I was like Audrey: Yes. Nathan Young: just barely old enough to watch them when they came out, so just dating myself there. So yeah, I love science being available and popularized and understandable. I will say one of the things, and I'm curious if if you've heard this too, or if this has been your experience also, if maybe this is shifting, because some of the feedback I've gotten from scientists I've talked to of and have worked with over the years to help them communicate outside the realm of science is just what you said. they're so used to speaking to each other and there's such a priority on speaking to each other versus the general public. But also there is a culture of They're very, very risk averse in embarrassing themselves potentially. Audrey: Okay. Nathan Young: And okay and Audrey: I am too. I'm like if someone could see me film a two minute video, the amount that I start over, delete, delete, delete, I said that word wrong. I didn't like the way it came out of my Nathan Young: Yeah. toilet, yes. Mm-hmm. Mm hmm Audrey: mouth. I didn't connect that properly. There is and I will say something like the fear of being perceived as not knowledgeable in your area is terrifying. Nathan Young: Mm-hmm. Mm-hmm. Audrey: it's something that I one hundred percent struggle with. And then also since I say I just graduated with my master's. I did it in May this year. There's this inherent I don't feel like I'm quite knowledgeable enough to position myself in this area of being an expert or being able to teach people because there's people that have been doing it for years. And so it's Nathan Young: Yeah, too. Mm-hmm. Yeah. Audrey: not something that I don't struggle. I struggle with it. Every Nathan Young: Mm-hmm. Audrey: single time I post a video, I'm checking. I'm like, did someone say I said something wrong? Did someone say I Nathan Young: Yeah. Audrey: didn't do this right? Is there any negative feedback on the video? I'm because I'm always open to feedback. I don't like when people say I didn't do something right, but when you're like, hey, I would love a video on this, 100%. Nathan Young: Mm-hmm. Audrey: Or if I didn't cover something, they're like, hey, this would be really cool if you touched on this and how it pertains to this. I'm more than willing to hear things like that. But the fear of being honestly just perceived in a social platform or just in the Nathan Young: Mm-hmm. Yeah. Audrey: world is can be debilitating to people. And it's Nathan Young: Yeah. Audrey: something that I definitely don't struggle with as much as I used to. Nathan Young: Mm-hmm. Audrey: And I feel like exposure is one of the best ways to get through Nathan Young: Yeah. Audrey: it. Nathan Young: Yeah. Well I'm curious if about this too, 'cause one of the something I've heard over the years is that there could be consequences too. if you are a researcher and so much of your ability to research is dependent on grants, and so much of those grants are dependent on essentially like your reputation. And so a lot of people that I've coached and taught and we worked with is yeah, they would almost rather fail but not embarrass themselves. just do something very simple and not make an impact with their talk at all, but not embarrass themselves rather than try to stretch and have greater success and greater outreach, but potentially some risk also of potentially embarrassing themselves. And is that still kind of the case? Is that lessening as far as you could tell or Audrey: yeah, I would say there was a little bit when I first started posting, I would go onto my own personal social media and repost it onto my story. Nathan Young: Mm-hmm. Mm-hmm. Audrey: That is something that terrifies me. I don't want to sit here and post myself as someone that does I've judged people. I've seen things and been like, that's interesting what that person's doing. But I've learned inherently, it doesn't really matter. there's always going to be people that think what you're doing is embarrassing. And it's something that I sort of stopped thinking about. I've talked about it a lot with my mom, with my partner, with family and friends and people that are also doing this. there's a part of it that is embarrassing. You're talking to a camera, you're by yourself. It feels ridiculous. You're Nathan Young: Yeah, yeah. It feels ridiculous sometimes. Audrey: editing out single ums and words and pauses because the way that you spoke was too slow. And there is a part of it that is embarrassing, but I've learned that ultimately I don't really care if someone else finds what I'm doing embarrassing. I enjoy what I do and I've been having Nathan Young: Mm-hmm. Audrey: a really great time doing it and it's opened up so many conversations like this and so many opportunities Nathan Young: Mm-hmm. Totally. Audrey: that I would not have had access to if I didn't do this. Nathan Young: Yeah, yeah. Cool. Well so yeah, what is next for Hot Girl Pharma then? where are you working on now? Audrey: I am working on a lot on my website. I am trying to make and it's not available now. I'm don't know when this episode will be available, but I'm trying to get things done. Yeah. Perfect. Nathan Young: Yeah, it might be a month or two or more. Audrey: That's perfect. I am trying to make one of the biggest things that I've heard people talk about is they're like, I can't get research articles because they're behind paywalls. So something Nathan Young: Mm-hmm, mm-hmm. Audrey: I'm actively trying to do, I don't know if I'll get in trouble for this, but Almost every single author that publishes a paper that then gives it to a publisher and they put it on their journal, their website, something like that, and they put it behind a paywall, the scientists are not getting a paycheck from that. They it's all just for the publishing company. So something that I've been actively doing is reaching out to papers that I find particularly interesting. I do have access to paywalled institutions because of being in academia. And then I also have access to these researchers where they're able to like, here's a downloadable PDF of this article Nathan Young: Mm-hmm. Audrey: that's twenty dollars on this one website. And Nathan Young: Mm-hmm. Audrey: so I'm making a comprehensive like list and I'm putting it onto my website so that people can access resources that they wouldn't necessarily have access to. And then I'm also making sort of guides on how to Nathan Young: Mm-hmm. Audrey: navigate credibility behind scientific media and how to conduct research yourself to be able to find the correct papers and articles and information that you want to know about. and then as well as references to almost every single one of my talks, references that I use in my media and stuff like that, I really like making the research accessible. So that's something that I've been doing just across the board. I do live lectures throughout San Diego. So if anyone is interested in hearing those, they can find information on my social media. I have one coming up on October twentieth in North Park in San Diego. And then perfect. and then Nathan Young: This won't come out by then. But Audrey: I'm working with a couple other places for talks in the beginning of the new year. So everything kind of comes to a halt around the holidays, which I feel like is what we're getting to. Nathan Young: Mm-hmm. Audrey: But definitely the media will be the most of it. People can find me on Hot Girl Pharma on Instagram, TikTok. that's also my website. And then talks will be coming out in the coming months and in the new year as well. So that's sort of how people can reach me. Yes, yes. Nathan Young: Yeah. Cool. We'll get you for big idea night one of these days too. We got you on there. Yes. Yeah, told so well cool. Well that yeah, seems like a pretty natural place to wrap this up then. So Audrey: Yeah. Nathan Young: yeah, and all those things you mentioned, we'll put them all in the show notes, all the links and everything too, so people can access Audrey: Perfect. Nathan Young: them there. I don't know, anything else you want to add before call here? Audrey: no. Thank you for having me. This was amazing. I really enjoyed this conversation and I feel like it was productive not only for me to understand where people that aren't like, you give me another insight into the world of Nathan Young: Mm-hmm. Audrey: the people that I'm trying to communicate to. So it was informative for me and I hope the listeners take something away that they learn from this. Yeah. Nathan Young: Yeah, totally, totally. Yeah. No, we we always appreciate it and it's funny this podcast has got all my little sort of pet things of that I'm not like but it's like science communication and fundraising and media literacy. So all the like things that I think about a lot but these are such important Audrey: Mm-hmm. Nathan Young: things in our world, but they're they're sort of niche. But I always love to be able to create space for these kind of conversations too. So I appreciate you coming on here and sharing with us. Audrey: Yeah, no. it's a great space. I had a great time and I listened to the podcast, so I look forward to hearing more episodes. Nathan Young: Cool, cool. awesome. Well, Audrey Tharp, Hot Girl Pharma, thanks for joining us and we'll talk again soon. All right, bye bye. Audrey: Thank you so much, Nathan. Talk to you soon. Bye. Nathan Young: Thanks so much to Audrey Tharp from Hot Girl Pharma for joining us for this conversation. One thing I'm really taking out of this is is that making science accessible isn't the same as making it sound simple or certain. And I think that's really a valuable point because a lot of times we do really put an emphasis on oversimplifying it to the point of certainty and that nuance does get lost. So maybe the more reasonable and responsible thing we can do is help people understand what the evidence says and what it doesn't say and who has and hasn't been included in the research. and I think just also the methodologies around science And what we're actually reading when we read an article that says quote unquote studies show. another valuable point that Audrey made is that promising treatments don't exist in a vacuum. The protocol, screening, therapy, and the people receiving the treatments all matter. so we can be excited about what research might make possible without turning that excitement into a promise That the science hasn't actually earned. if you wanna catch more of what Audrey's doing, you can go to Hot Girl Pharma. She's got that account on a number of different social media channels, all of which we will link in the show notes. and obviously she's got a website as well, which is we will also link in the show notes. So I hope you enjoyed this conversation and with that we will see you on the next Braver New Worlds. Bye.